NEW HAVEN >> Scientists from Yale University and the University of Cambridge in England have teamed up to develop a potential cure for multiple sclerosis.
Its the first treatment that addresses the disease by disarming the immune cells that have turned against the bodys nerve cells, rather than simply suppressing them. An autoimmune disease, MS begins when parts of the bodys immune system, rather than fighting off disease, begin to attack healthy cells.
Su Metcalfe, senior research associate in the University of Cambridge Clinical School, discovered the molecular process that stops the attack on the protective myelin sheath around nerves in the brain and central nervous system. Its that destruction of myelin that causes MS.
Tarek Fahmy, associate professor of biomedical engineering and of immunobiology in the Yale School of Engineering and Applied Science, created the delivery system that brings Metcalfes treatment to the site of the disease.
Multiple sclerosis is a devastating disease that can attack people as young as 30, slowly reducing their brain volume, Metcalfe said. Theyre looking forward to 40 years of slowly getting worse, she said. Its a horrible disease and it costs the global economy $100 billion a year.
According to the National Multiple Sclerosis Society, there are more than 2.3 million cases worldwide, but the society doesnt provide an estimate of U.S. cases because doctors are not required to report new cases. There are a wide variety of symptoms, including fatigue, numbness and tingling muscles, slurred speech, walking difficulties and muscle spasms.
Among the cells in the immune system are T lymphocytes, or T cells. One of their functions is to produce molecules called cytokines, which specialize in alerting immune system cells to infection, cancer or any foreign intrusion in the body, Fahmy said. The immune cells then rush to the site to fight the disease, he said.
However, T cells can go awry and turn from fighting disease to attacking the bodys own cells. In these disease states the T cells make an error whose root cause is still an enigma to scientists and clinicians, Fahmy said. If this happens, then these malfunctioned T cells will produce cytokines that bring in more T cells to the site and the illness cascade of events begins.
He said the same process also is involved in other autoimmune diseases, such as type 1 diabetes and lupus.
Metcalfe said that in 2005 she discovered that another cytokine, called leukemia inhibitory factor, or LIF, regulates the immune response to stop autoimmune attack. The molecule controls a switch that turns the T cells from destroyers to protectors. The way LIF acts on T cells was a critical discovery, she said.
That was a world first, and we discovered that theres a binary switch in the cell so the cell can either become tolerant or aggressive and that switch is operated by LIF, Metcalfe said.
LIF comes in and cuts off the signal that calls in more T cells, Fahmy said.
The challenge to getting LIF to the diseased site was that it is a short-lived molecule. It breaks down within 20 minutes, Metcalfe said. So a way had to be found to deliver it to the T cells. Thats where Fahmys engineering expertise came in.
Fahmy confronted two issues in addition to LIFs delicate nature. One is to avoid having LIF turn off the immune properties of cells throughout the body, the way chemotherapy attacks both healthy and cancerous cells. It has to be targeted to those areas and it has to be a long-lasting signal as well, Fahmy said.
A third factor is we need a high concentration of LIF in that area, he said. The question then becomes, how do you get a high amount of nullifying molecules to the area thats affected and to have those LIF molecules sustained over a long period of time.
Fahmys solution was to create a nanoparticle, one ten-thousandth the width of a human hair follicle (100 to 200 nanometers), which carries the LIF molecules to the T cell like a truck carrying cargo. He used the same material used in soluble stitches and coated it with a protein that only binds to those immune cells that are attacking the rogue T cells. Then, the nanoparticle was loaded with LIF molecules and freeze-dried.
When theyre exposed to water again, they start degrading and as they degrade they release the LIF, Fahmy said. So its like a new drug, except its using older materials, combining them together. Im very hopeful that this is going to work like how natural processes in the body work.
Fahmy said the nanoparticle delivery method is important because, given alone by itself, this drug LIF is a very toxic drug if administered to people without a delivery apparatus. Using the nanoparticle, the amount of LIF that needs to be delivered is 10,000-fold lower than if it were given directly.
Metcalfe and Fahmy have formed a company called LIFNano, which will bring their treatment to clinical trials by 2020. Im committed, Metcalfe said. Ive given my whole career, switched it over to treat patients.
Ive just received 1 million pounds from the U.K. government to do pre-clinical, pre-regulatory work. Part of that million pounds is going to Yale. So Yale remains very closely involved alongside and were continuing this synergistic value in taking this nano-medicine approach to treat patients, she said.
Metcalfe and Fahmy hope their therapy, treating the cells with a naturally occurring molecule, will eventually replace the standard treatment of giving immune-suppressant drugs, which carry their own risks.
This really is a whole new field of study that we call immune-engineering, and it promises to change how therapy will happen for cancer and autoimmune diseases, Fahmy said.
Theres nothing specific controlling the root cause of disease, which is what were doing, and in addition were repairing the myelin and protecting the nerves and theres nothing out there today that protects the nerves, Metcalfe said.
She said she has been at Cambridge her whole career and working to understand what controls lymphocytes and I found LIF. Its been a long journey.
Call Ed Stannard at 203-680-9382.
Link:
- Is there an alternative to radiation - November 8th, 2009 [November 8th, 2009]
- Taiwan exploring how nanotech affects health - November 8th, 2009 [November 8th, 2009]
- A new way of treating cancer on the way? - November 8th, 2009 [November 8th, 2009]
- Lasers can destroy cancer cells - November 8th, 2009 [November 8th, 2009]
- Fluorescent molecules can be biomarkers - November 8th, 2009 [November 8th, 2009]
- Quick blood tests by using a nanodevice - November 8th, 2009 [November 8th, 2009]
- Where will medicine be 20 years from now - November 8th, 2009 [November 8th, 2009]
- History of nanotechnology - November 8th, 2009 [November 8th, 2009]
- Nanotech and Cancer - November 8th, 2009 [November 8th, 2009]
- Nanotechnology in medicine - November 8th, 2009 [November 8th, 2009]
- How does cancer start - January 25th, 2010 [January 25th, 2010]
- Lung cancer symptoms - January 26th, 2010 [January 26th, 2010]
- Signs of breast cancer - January 27th, 2010 [January 27th, 2010]
- Famous people with cancer - January 29th, 2010 [January 29th, 2010]
- Metastatic renal cancer - January 30th, 2010 [January 30th, 2010]
- What causes skin cancer - January 31st, 2010 [January 31st, 2010]
- How many people die from cancer each year - February 1st, 2010 [February 1st, 2010]
- How much money is spent on cancer research - February 2nd, 2010 [February 2nd, 2010]
- Colon cancer warning signs - February 4th, 2010 [February 4th, 2010]
- Prostate cancer symptoms - February 4th, 2010 [February 4th, 2010]
- Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy - April 25th, 2012 [April 25th, 2012]
- Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy, other neurologic disorders - April 25th, 2012 [April 25th, 2012]
- Nanomaterial properties in complement activation: lessons from nanomedicine - Video - May 4th, 2012 [May 4th, 2012]
- OMICS Group :: International Conference and Exhibition on Nanotechnology - May 4th, 2012 [May 4th, 2012]
- Use of Nanotechnology in Medicine [FOX 11-27-2011] - Video - May 4th, 2012 [May 4th, 2012]
- Cancer Nanomedicine - Detection - Video - May 4th, 2012 [May 4th, 2012]
- Cancer Nanomedicine - Video - May 4th, 2012 [May 4th, 2012]
- HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011 - May 5th, 2012 [May 5th, 2012]
- Nano science, focus of Education Ministry - May 7th, 2012 [May 7th, 2012]
- Drug-resistant Bacteria - Designing Nanoparticles For High Antibiotic Doses - May 7th, 2012 [May 7th, 2012]
- Research and Markets: Global Market for Nano Silver - May 10th, 2012 [May 10th, 2012]
- Cracking study makes nanotech breakthrough - May 10th, 2012 [May 10th, 2012]
- Nanoparticles may pose environmental threat - May 16th, 2012 [May 16th, 2012]
- Global Nanobiotechnology Industry - May 17th, 2012 [May 17th, 2012]
- 'Inability to give back Singur land my biggest regret' - May 20th, 2012 [May 20th, 2012]
- 'KOREA PACK 2012' for Packing process industry to be held at KINTEX - May 23rd, 2012 [May 23rd, 2012]
- New ISO Technical Report Guides Characterization of Nanomaterials in Toxicology - May 29th, 2012 [May 29th, 2012]
- DNA strands create tiniest Smileys - May 30th, 2012 [May 30th, 2012]
- Health and fitness agenda: Evolution Asia Yoga Conference - June 2nd, 2012 [June 2nd, 2012]
- UC Davis work in humanities receives $150,000 in UC-wide grants - June 2nd, 2012 [June 2nd, 2012]
- Computer-designed proteins 'may help fight variety of flu viruses' - June 3rd, 2012 [June 3rd, 2012]
- 'Nano technology' [program can pay off big for IRSC students - June 3rd, 2012 [June 3rd, 2012]
- Computer-designed proteins programmed to disarm variety of flu viruses - June 3rd, 2012 [June 3rd, 2012]
- Jugaad innovators don't plan - they improvise - June 6th, 2012 [June 6th, 2012]
- Health and fitness agenda: World Blood Donor Day - June 9th, 2012 [June 9th, 2012]
- OMICS Group :: Journal of Nanomedicine - June 9th, 2012 [June 9th, 2012]
- Researchers develop a 'time bomb' to fight cardiovascular disease - June 10th, 2012 [June 10th, 2012]
- Nanotechnologists develop a 'time bomb' to fight cardiovascular disease - June 10th, 2012 [June 10th, 2012]
- 'Time bomb' to fight cardiovascular disease developed - June 11th, 2012 [June 11th, 2012]
- Asia's First Graphene Nano-Tech Facility Opens In Singapore - June 13th, 2012 [June 13th, 2012]
- How worms are pioneering remote control medicine - June 13th, 2012 [June 13th, 2012]
- Golden Helix Establishes Direct Presence in Japan - June 13th, 2012 [June 13th, 2012]
- STDs Blocked by Nano Gel, Study Suggests - June 15th, 2012 [June 15th, 2012]
- Real Products, Different Results - June 15th, 2012 [June 15th, 2012]
- The Puridone Program - A Breakthrough for Painkiller Addiction - June 15th, 2012 [June 15th, 2012]
- Six startup medical device firms compete in Memphis for fame and fortune - June 19th, 2012 [June 19th, 2012]
- International Nanomedicine Conference bound for Sydney: July 2-4, 2012 - June 19th, 2012 [June 19th, 2012]
- Taming light with graphene - June 21st, 2012 [June 21st, 2012]
- Today on New Scientist: 25 June 2012 - June 26th, 2012 [June 26th, 2012]
- A step towards the future - July 1st, 2012 [July 1st, 2012]
- Genia Technologies Collaborates with Professors Jingyue Ju at Columbia and George Church at Harvard to Develop a ... - October 4th, 2012 [October 4th, 2012]
- Scientists Invited To Submit Proposals For Biological Research In Space - October 4th, 2012 [October 4th, 2012]
- Research and Markets: Micro-Nano Technology XIII from the 13th Annual Conference of Chinese Society of Micro-Nano ... - October 6th, 2012 [October 6th, 2012]
- $80M research facility to open at UMass Lowell - October 6th, 2012 [October 6th, 2012]
- Nano-revolution in drugs delivery - October 8th, 2012 [October 8th, 2012]
- SENAI/SESI of Sao Paulo Selects NanoProfessor as Foundation for "Nanomundo" Nanotechnology Education Initiative - October 8th, 2012 [October 8th, 2012]
- Delivering an integral approach to emotional and mental health - October 9th, 2012 [October 9th, 2012]
- NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting - October 11th, 2012 [October 11th, 2012]
- Il Nano Mondo del professor Ennio Tasciotti - Video - October 30th, 2012 [October 30th, 2012]
- Deakin University - Practical Science - Nano medicine - Video - October 30th, 2012 [October 30th, 2012]
- 2012 Deakin University 3 Minute Thesis Finalist - Jarrad Altimari - Video - October 30th, 2012 [October 30th, 2012]
- Nano Medicine from "Development of Nanotechnology in Hong Kong" - Video - October 30th, 2012 [October 30th, 2012]
- NANO Medicine 1 3 xvid - Video - October 30th, 2012 [October 30th, 2012]
- Nanolääke // Nano medicine - Video - October 30th, 2012 [October 30th, 2012]
- NANO Medicine (1-3) - Video - October 30th, 2012 [October 30th, 2012]
- Jefferson County, Colorado's Bioscience Industry - Video - October 30th, 2012 [October 30th, 2012]
- NanoMission - Nanomedicine NanoBot - Video - October 30th, 2012 [October 30th, 2012]
- Study aims to unlock mysteries of autism - November 20th, 2012 [November 20th, 2012]
- Catherine Griwkowsky - November 22nd, 2012 [November 22nd, 2012]
- Kulkarni to be feted at Bangalore Nano 2012 - November 26th, 2012 [November 26th, 2012]